InMobi Acquires Quantcast Choice to Enhance Frictionless Consent Management for Publishers
SAN MATEO, Calif.–(BUSINESS WIRE)–InMobi, a leading provider of content monetization and marketing technologies that help…
News
AgSights Signs Strategic Commercial Agreement with HerdWhistle Technologies Inc.
Calgary, Alberta–(Newsfile Corp. – August 15, 2023) – Having recently announced its Game-Changing Partnership with…
Ex-Singapore Parliamentarian’s Swiss Company Launches Swiss Franc and Euro Stablecoins
Singapore investor and former parliamentarian Calvin Cheng’s newly rebranded Swiss company, Anchored Coins, was granted…
New Research by Ivanti Reveals a Quarter of IT Professionals are Considering Quitting Their Job in the Next Six Months
This exodus of IT workers has the potential to cost US employers more than 145…
Faraday Future Launches the Developer Co-Creation Officer Recruitment Platform and Releases the First FF 91 2.0 Futurist Alliance Delivery Ceremony Video
Inaugural FF 91 2.0 Futurist Alliance delivery ceremony video posted. Online registration for FF Developer…
ElectroNeek Among Top 10% of Companies on 2023 Inc. 5000 List
AUSTIN, Texas–(BUSINESS WIRE)–#automation–ElectroNeek, the leading intelligent automation platform for Managed Service Providers (MSP) and Businesses…
MediciNova Receives a New Patent Covering MN-001 for the Treatment of Scleroderma and Systemic Sclerosis in Europe
LA JOLLA, Calif., Aug. 15, 2023 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded…
MediciNova Receives a New Patent Covering MN-001 for the Treatment of Scleroderma and Systemic Sclerosis in Europe
LA JOLLA, Calif., Aug. 15, 2023 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded…
Intel and Synopsys Expand Partnership to Enable Leading IP on Intel Advanced Process Nodes
NEWS HIGHLIGHTS Multi-generational agreement advances Intel’s IDM 2.0 strategy. Partnership broadens and accelerates IP access…
Impro Precision: Interim results continue to improve, stock price rises amid adversity, and US peer also climbs to new high
HONG KONG, Aug 16, 2023 – (ACN Newswire) – Impro Precision (01286.HK), the world’s sixth…
Kingworld Further Subscribed For 2.08% Equity of Taiko Pharmaceutical To Optimize Its Layout of Pharmaceutical Industry
HONG KONG, Aug 16, 2023 – (ACN Newswire) – Kingworld Medicines Group Limited (“Kingworld Medicines”…
Shareholder Alert: Robbins LLP Informs Shareholders of Class Action Filed Against Applied Digital Corporation (APLD)
SAN DIEGO–(BUSINESS WIRE)–$APLD #APLD—Robbins LLP informs investors that a shareholder filed a class action on…
Sidus Space Reports Record Q2 2023 Gross Margin
Gross margin nearly doubles to 37% for the quarter ended June 30, 2023, improving 1,800…
BioSyent Schedules Q2 and H1 2023 Earnings Release for August 22, 2023
MISSISSAUGA, Ontario, Aug. 15, 2023 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture:…
BioSyent Schedules Q2 and H1 2023 Earnings Release for August 22, 2023
MISSISSAUGA, Ontario, Aug. 15, 2023 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture:…
NANOBIOTIX Announces Expiration of HSR Waiting Period Regarding the Agreement for Worldwide Co-Development and Commercialization of Potential First-in-Class Radioenhancer NBTXR3
PARIS and CAMBRIDGE, Mass., Aug. 15, 2023 (GLOBE NEWSWIRE) — NANOBIOTIX (Euronext: NANO –– NASDAQ:…
NANOBIOTIX Announces Expiration of HSR Waiting Period Regarding the Agreement for Worldwide Co-Development and Commercialization of Potential First-in-Class Radioenhancer NBTXR3
PARIS and CAMBRIDGE, Mass., Aug. 15, 2023 (GLOBE NEWSWIRE) — NANOBIOTIX (Euronext: NANO –– NASDAQ:…
Sagimet Biosciences Announces Closing of Underwriters’ Option to Purchase Additional Shares of Series A Common Stock in Connection with its Upsized Initial Public Offering
SAN MATEO, Calif., Aug. 15, 2023 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (“Sagimet”) (Nasdaq: SGMT),…
Sagimet Biosciences Announces Closing of Underwriters’ Option to Purchase Additional Shares of Series A Common Stock in Connection with its Upsized Initial Public Offering
SAN MATEO, Calif., Aug. 15, 2023 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (“Sagimet”) (Nasdaq: SGMT),…
MediWound Reports Second Quarter 2023 Financial Results and Provides Company Update
EscharEx® Phase III study protocol: FDA/EMA-aligned; patient enrollment commencing early 2024; two key research collaborations…